News stories about Sigma Labs (NASDAQ:SGLB) have trended somewhat positive this week, Accern Sentiment reports. Accern rates the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Sigma Labs earned a coverage optimism score of 0.07 on Accern’s scale. Accern also gave news coverage about the company an impact score of 45.4058611189626 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Sigma Labs (NASDAQ SGLB) opened at $1.71 on Thursday. The stock has a market capitalization of $8.66, a PE ratio of -2.28 and a beta of 0.85. Sigma Labs has a 1 year low of $1.33 and a 1 year high of $9.20.

Sigma Labs (NASDAQ:SGLB) last released its quarterly earnings data on Tuesday, November 14th. The company reported ($0.24) earnings per share (EPS) for the quarter. The business had revenue of $0.08 million for the quarter. Sigma Labs had a negative return on equity of 98.15% and a negative net margin of 393.24%.

In other news, insider Mark Cola sold 7,874 shares of the company’s stock in a transaction dated Friday, December 22nd. The stock was sold at an average price of $3.25, for a total transaction of $25,590.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 6.06% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another site, it was stolen and republished in violation of United States & international copyright & trademark law. The original version of this report can be viewed at

About Sigma Labs

Sigma Labs, Inc is a technology company that specializes in the development and commercialization of manufacturing and materials technologies. The Company’s principal business activities include the development of its In-Process Quality Assurance (IPQA) suite of technologies and the commercialization of both its IPQA and materials-related suite of technologies, with its focus on three-dimensional printing (3DP) industry.

Insider Buying and Selling by Quarter for Sigma Labs (NASDAQ:SGLB)

Receive News & Ratings for Sigma Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigma Labs and related companies with's FREE daily email newsletter.